0.5473 USD
+0 (+0.15%)
Taking everything into account, NOTV scores 2 out of 10 in our fundamental rating. NOTV was compared to 57 industry peers in the Life Sciences Tools & Services industry. Both the profitability and financial health of NOTV have multiple concerns. NOTV is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year NOTV has reported negative net income.
NOTV had a negative operating cash flow in the past year.
In the past 5 years NOTV reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: NOTV reported negative operating cash flow in multiple years.
1.2 Ratios
With a Return On Assets value of -8.90%, NOTV perfoms like the industry average, outperforming 49.12% of the companies in the same industry.
NOTV has a worse Return On Equity (-50.45%) than 73.68% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -8.9% | ||
| ROE | -50.45% | ||
| ROIC | N/A |
ROA(3y)-11.68%
ROA(5y)-13.33%
ROE(3y)-51.04%
ROE(5y)-47.25%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Gross Margin, with a value of 23.58%, NOTV is doing worse than 80.70% of the companies in the same industry.
In the last couple of years the Gross Margin of NOTV has declined.
The Profit Margin and Operating Margin are not available for NOTV so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 23.58% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.34%
GM growth 5Y-4.75%
2. Health
2.1 Basic Checks
NOTV does not have a ROIC to compare to the WACC, probably because it is not profitable.
NOTV has more shares outstanding than it did 1 year ago.
The number of shares outstanding for NOTV has been increased compared to 5 years ago.
NOTV has a worse debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of -1.17, we must say that NOTV is in the distress zone and has some risk of bankruptcy.
NOTV has a Altman-Z score of -1.17. This is amonst the worse of the industry: NOTV underperforms 80.70% of its industry peers.
A Debt/Equity ratio of 0.04 indicates that NOTV is not too dependend on debt financing.
NOTV has a better Debt to Equity ratio (0.04) than 64.91% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.04 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -1.17 |
ROIC/WACCN/A
WACC8.02%
2.3 Liquidity
NOTV has a Current Ratio of 0.35. This is a bad value and indicates that NOTV is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.35, NOTV is not doing good in the industry: 96.49% of the companies in the same industry are doing better.
A Quick Ratio of 0.27 indicates that NOTV may have some problems paying its short term obligations.
NOTV has a Quick ratio of 0.27. This is amonst the worse of the industry: NOTV underperforms 96.49% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.35 | ||
| Quick Ratio | 0.27 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 47.02% over the past year.
NOTV shows a small growth in Revenue. In the last year, the Revenue has grown by 4.54%.
Measured over the past years, NOTV shows a very strong growth in Revenue. The Revenue has been growing by 53.35% on average per year.
EPS 1Y (TTM)47.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%65.75%
Revenue 1Y (TTM)4.54%
Revenue growth 3Y-2.16%
Revenue growth 5Y53.35%
Sales Q2Q%5.92%
3.2 Future
Based on estimates for the next years, NOTV will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.30% on average per year.
Based on estimates for the next years, NOTV will show a quite strong growth in Revenue. The Revenue will grow by 14.55% on average per year.
EPS Next Y8.11%
EPS Next 2Y10.3%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.92%
Revenue Next 2Y4.94%
Revenue Next 3Y18.59%
Revenue Next 5Y14.55%
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
NOTV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year NOTV is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
77.19% of the companies in the same industry are more expensive than NOTV, based on the Enterprise Value to EBITDA ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 18.96 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y10.3%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for NOTV!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NASDAQ:NOTV (12/31/2025, 11:40:31 AM)
0.5473
+0 (+0.15%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners23.86%
Inst Owner Change-3.16%
Ins Owners9.64%
Ins Owner Change0%
Market Cap18.81M
Revenue(TTM)513.02M
Net Income(TTM)-68.63M
Analysts80
Price Target4.93 (800.79%)
Short Float %7.37%
Short Ratio2.37
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)24.82%
Min EPS beat(2)2.91%
Max EPS beat(2)46.72%
EPS beat(4)3
Avg EPS beat(4)19.11%
Min EPS beat(4)-5.26%
Max EPS beat(4)46.72%
EPS beat(8)5
Avg EPS beat(8)-15.76%
EPS beat(12)7
Avg EPS beat(12)-9.79%
EPS beat(16)11
Avg EPS beat(16)102.67%
Revenue beat(2)1
Avg Revenue beat(2)0.36%
Min Revenue beat(2)-0.13%
Max Revenue beat(2)0.84%
Revenue beat(4)1
Avg Revenue beat(4)-1.12%
Min Revenue beat(4)-3.54%
Max Revenue beat(4)0.84%
Revenue beat(8)2
Avg Revenue beat(8)-2.65%
Revenue beat(12)5
Avg Revenue beat(12)-0.61%
Revenue beat(16)8
Avg Revenue beat(16)2.26%
PT rev (1m)-12.12%
PT rev (3m)-12.12%
EPS NQ rev (1m)-25.49%
EPS NQ rev (3m)-25.49%
EPS NY rev (1m)-11.11%
EPS NY rev (3m)-11.11%
Revenue NQ rev (1m)-4.44%
Revenue NQ rev (3m)-4.44%
Revenue NY rev (1m)0.22%
Revenue NY rev (3m)0.22%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.04 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.14 | ||
| P/tB | N/A | ||
| EV/EBITDA | 18.96 |
EPS(TTM)-2.22
EYN/A
EPS(NY)-2.04
Fwd EYN/A
FCF(TTM)-0.79
FCFYN/A
OCF(TTM)-0.3
OCFYN/A
SpS14.93
BVpS3.96
TBVpS-5.78
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -8.9% | ||
| ROE | -50.45% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 23.58% | ||
| FCFM | N/A |
ROA(3y)-11.68%
ROA(5y)-13.33%
ROE(3y)-51.04%
ROE(5y)-47.25%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.34%
GM growth 5Y-4.75%
F-Score5
Asset Turnover0.67
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.04 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 0.26 | ||
| Cap/Depr | 29.71% | ||
| Cap/Sales | 3.24% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.35 | ||
| Quick Ratio | 0.27 | ||
| Altman-Z | -1.17 |
F-Score5
WACC8.02%
ROIC/WACCN/A
Cap/Depr(3y)39.68%
Cap/Depr(5y)78.3%
Cap/Sales(3y)4.2%
Cap/Sales(5y)6.63%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)47.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%65.75%
EPS Next Y8.11%
EPS Next 2Y10.3%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.54%
Revenue growth 3Y-2.16%
Revenue growth 5Y53.35%
Sales Q2Q%5.92%
Revenue Next Year4.92%
Revenue Next 2Y4.94%
Revenue Next 3Y18.59%
Revenue Next 5Y14.55%
EBIT growth 1Y32.29%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year281.84%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y7.02%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-53.64%
OCF growth 3YN/A
OCF growth 5YN/A
INOTIV INC / NOTV FAQ
Can you provide the ChartMill fundamental rating for INOTIV INC?
ChartMill assigns a fundamental rating of 2 / 10 to NOTV.
Can you provide the valuation status for INOTIV INC?
ChartMill assigns a valuation rating of 1 / 10 to INOTIV INC (NOTV). This can be considered as Overvalued.
What is the profitability of NOTV stock?
INOTIV INC (NOTV) has a profitability rating of 1 / 10.
Can you provide the expected EPS growth for NOTV stock?
The Earnings per Share (EPS) of INOTIV INC (NOTV) is expected to grow by 8.11% in the next year.